Pharmacogenomics
Volume 25, 2024 - Issue 4
Research Article
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities
Danyi Wang1 EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaAUSA
https://orcid.org/0000-0002-4780-3471
https://orcid.org/0000-0002-4780-3471, Jayaprakasam Bolleddula1 EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaAUSAhttps://orcid.org/0000-0003-4700-7819
https://orcid.org/0000-0003-4700-7819, , Thomas Grombacher2 Merck Healthcare KGaA, Darmstadt, Germanyhttps://orcid.org/0000-0001-9855-7429
https://orcid.org/0000-0001-9855-7429, , , & Zheng Feng1 EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaAUSACorrespondence[email protected]
https://orcid.org/0000-0003-3858-2205
https://orcid.org/0000-0003-3858-2205 show all